Football chairman takes shine to Italian device firm:
This article was originally published in Clinica
Italian entrepreneur Giuseppe Gazzoni Frascara is interested in purchasing implant manufacturer Officine Ortopediche Rizzoli, says Il Corriere della Sera. The main shareholders in the company are Istituto Rizzoli (70%), the Region of Emilia Romagna and the provincial and local authorities of Bologna (24%) and a group of private investors. Mr Gazzoni Frascara is chairman of Gazzoni SpA and of Bologna football club. His interest in the implant manufacturer is "personal".
You may also be interested in...
ConMed Corp. is company of two halves ̶ general surgery and orthopedics – and is readying itself for a renewed assault on these two markets on the back of a technology pipeline, targeted acquisitions and a new growth-winning culture, says CFO Todd Garner.
Drug pricing and access issues expose the pharmaceutical sector especially acutely to calls for companies to meet ethical and social goals, alongside commercial ones. Digital is up-ending pharma’s processes, its workplaces and its consumers. R&D productivity is spluttering. Amid this turmoil, CEOs highlight company culture – the way an organization behaves – as a crucial ingredient for success. But what is a “right” culture? Organizational culture is neither static nor singular. It is continuously influenced by acquisitions, markets, new technologies and new generations. And pharma’s history suggests that culture change cannot happen without sufficient people change.